Logo

BioTrove Licenses Microarray from Stanford, Gets Patent

Jul 15, 2004

NEW YORK, July 15 (GenomeWeb News) - BioTrove announced Thursday that it has acquired an exclusive license from Stanford University for patent applications covering the use of a through-hole structured microarray to perform PCR.

 

BioTrove also said it has received a patent on a novel method using the company's proprietary OpenArray platform for high-density cell assay and culture. BioTrove is commercializing the platform, a nanofluidic system for massively parallel analysis using Thru-Hole technology, for use by life science researchers.

 

The patent covers an innovative application of the OpenArray technology that allows for the maintenance and growth of cells in a microfluidic environment, with potential application in cell-based assays.

 

BioTrove's through-hole intellectual property portfolio now includes eight patents issued or allowed and numerous patents pending, according to the Woburn, Mass.-based firm.

 

 

Breaking News
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.